Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

Integra LifeSciences (Nasdaq: IART) announced that CFO Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT.

Rhea-AI Summary

Integra LifeSciences (Nasdaq: IART) announced that CFO Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT. A live webcast will be available on the Integra investor relations site under Events & Presentations.

Argus May 8 session

+2.65% close to close Open Argus

Details

News Market Reaction – IART

In the May 8 session, IART gained 2.65%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Integra LifeSciences’ participation in the BofA Securities 2026 Health ...

Analysis

This announcement highlights Integra LifeSciences’ participation in the BofA Securities 2026 Health Care Conference, following a series of more material updates on earnings, guidance, and leadership. Recent filings detailed Q1 2026 revenue of $391.9M, raised adjusted EPS guidance to $2.40–$2.50, and net debt of $1.60B. Investors may watch how management’s conference messaging tracks with these disclosures and the company’s transformation initiatives discussed in recent 10‑Q and 8‑K filings.

Key Figures

Q1 2026 revenue: $391.9M Q1 2026 GAAP EPS: $(0.06) Q1 2026 adjusted EPS: $0.54 +5 more

Q1 2026 revenue

$391.9M

Quarter ended March 31, 2026 (10-Q and 8-K)

Q1 2026 GAAP EPS

$(0.06)

Quarter ended March 31, 2026 (8-K)

Q1 2026 adjusted EPS

$0.54

Quarter ended March 31, 2026 (8-K)

2026 revenue guidance

$1.662B–$1.702B

Full-year 2026 guidance (8-K)

2026 adjusted EPS guidance

$2.40–$2.50

Raised full-year 2026 outlook (8-K)

Net debt

$1.60B

As of Q1 2026 (8-K)

Total liquidity

$488M

As of Q1 2026 (8-K)

Operating cash flow

$9.8M

Q1 2026 cash from operations (10-Q)

Historical Context

5 past events · Latest: May 05

5 events

1. May 05

   Leadership transition

   24h Move

   +24.1%

   CEO change with Stuart Essig appointed president and chief executive officer.

2. May 05

   Q1 2026 earnings

   24h Move

   +24.1%

   Q1 2026 results with $391.9M revenue and raised adjusted EPS guidance.

3. Apr 20

   Earnings call notice

   24h Move

   +0.2%

   Announcement of date and time for Q1 2026 earnings release and call.

4. Apr 07

   Clinical data update

   24h Move

   +0.2%

   New real-world PriMatrix data from 985 cases and a 23-patient burn series.

5. Feb 26

   FY 2025 earnings

   24h Move

   -2.2%

   Q4 and 2025 results with GAAP loss driven by $511M goodwill impairment.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.

About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 

Integra LifeSciences Holdings Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Integra LifeSciences (IART) present at the BofA Securities 2026 Health Care Conference?

Integra LifeSciences (IART) will present on May 12, 2026 at 4:20pm PT. According to the company, the presentation will be delivered by CFO Lea Knight and is part of the conference schedule for investor-facing events.

Who from Integra LifeSciences (IART) is presenting at the BofA Securities 2026 Health Care Conference?

CFO Lea Knight will present for Integra LifeSciences (IART) at the conference. According to the company, the presentation is a company-hosted investor event and will be available via a live webcast for remote viewers.

How can investors watch Integra LifeSciences (IART) presentation at the BofA Securities 2026 Health Care Conference?

Investors can watch a live webcast on Integra's investor relations website under Events & Presentations. According to the company, the webcast will stream the CFO's presentation and may include slides or Q&A as provided during the session.

Will Integra LifeSciences (IART) provide slides or a replay of the BofA Securities 2026 presentation?

A live webcast will be available, and replays or presentation materials are typically posted afterward on the investor site. According to the company, materials and replay access are usually published under Events & Presentations following the live session.